ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Revealing Robust Atomic Configurations of the Ligand-Assisted Synthesized High-Entropy PtIrFeCoNiCu Nano-Intermetallic Catalysts During Oxygen Reductions in Fuel Cells.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Revealing Robust Atomic Configurations of the Ligand-Assisted Synthesized High-Entropy PtIrFeCoNiCu Nano-Intermetallic Catalysts During Oxygen Reductions in Fuel Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Despite excellent catalytic performance via the "cocktail effect" and the phase stability of high-entropy alloys (HEAs), their multicomponent surface remains inadequately explored after oxygen reduction reaction (ORR). Moreover, the facile synthesis of nano HEAs is required for practical applications. Herein, nanosized (∼4.8 nm) carbon-supported PtIrFeCoNiCu intermetallics (PtIr-iHEA/C), ∼90% ordered, are prepared through a mercaptosuccinic acid (MSA)-assisted strategy. Combining atomic-level characterizations and theoretical calculations, the activity is correlated with the evolving surface configuration. Leveraging the activated Pt and Fe sites, PtIr-iHEA/C displays an initial mass activity (MA) of 1.65 A mg
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.